GLP-1 & Metabolic Health

Last updated
Jul 20, 2026
Based on
226 actions
Gurus considered
148
Stocks covered
170

Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 226 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 148 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.

GLP-1 & Metabolic Health Smart Money Notes

Rosenberg AaronCFO

Sell $162.6K of disclosed value in BeOne Medicines Ltd. $ONC.

Sell

Hansen GwennCSO

Sell $107.9K of disclosed value in Nurix Therapeutics, Inc. $NRIX.

Sell

Bharucha DavidCMO

Sell $134.6K of disclosed value in Milestone Pharmaceuticals Inc. $MIST.

Sell

Muller LorenzCCO

Sell $124.3K of disclosed value in Milestone Pharmaceuticals Inc. $MIST.

Sell

Bjerkholt EricCFO

Sell $101.3K of disclosed value in Mirum Pharmaceuticals, Inc. $MIRM.

Sell

PRIMECAP Management

Trim transactions in Eli Lilly and Co $LLY, Insulet Corp $PODD, Pulmonx Corporation $LUNG, and BeOne Medicines Ltd. $ONC.

Trim

First Eagle Investments

Add transactions in Brookdale Senior Living Inc. $BKD, LifeStance Health Group, Inc. $LFST, Beta Bionics, Inc. $BBNX, and Talkspace, Inc. $TALK.

Add

Jefferies Group

Trim transactions in AdaptHealth Corp. - Class A $AHCO $AHCO, Eli Lilly and Co $LLY, and PTC THERAPEUTICS, INC. $PTCT.

Trim
Showing 181-210 of 226